Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

HHS recently terminated a $766 million award to Moderna for developing mRNA vaccines against influenza viruses that run a risk of causing a pandemic, in the midst of an ongoing H5N1 bird flu ...

Moderna's mRNA-based flu vaccine funding is cancelled by the Department of Health and Human Services, arguing lack of scientific and ethical justification.

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the company’s shot.

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market. MRNA’s Court Victory A German court ruled that BioNTech (BNTX) and ...

However, right now, it is still seeing stagnating sales as fewer and fewer people get the mRNA vaccine for COVID-19. This is the key reason Moderna stock is in a 90% drawdown.